DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Research

June 3, 2025
PCNSL Clinical Trial

Explore a Phase 2 clinical trial for Primary Central Nervous System Lymphoma (PCNSL). Learn about eligibility and enrollment details at EndBrainCancer.org.

Read More
April 10, 2025
PET Scan Imaging Agents

Positron Emission Tomography (PET) is a powerful imaging technique that uses radioactive tracers called imaging agents.

Read More
March 27, 2025
Meet Dr. John de Groot

Hear directly from Dr. John de Groot about TLX101-CDx, an agent for the imaging of gliomas.

Read More
February 27, 2025
GBM Advisory Board

CISCRP is looking for adult patients diagnosed with Glioblastoma and/or their caregivers to participate in an advisory board.

Read More
February 20, 2025
Promising Pathway Act

Advocate for the Promising Pathway Act (S. 4426). Share your story and its importance.

Read More
February 18, 2025
Know All Your Treatment Options 2025

Discover brain cancer treatment options for 2025. Learn about clinical trials, personalized medicine, and patient advocacy from the End Brain Cancer Initiative.

Read More
February 14, 2025
10-Minute PCNSL Survey

You have the opportunity to make a difference by sharing your experience and insights related to Primary Central Nervous System Lymphoma (PCNSL)!

Read More
February 4, 2025
Don't Miss the PCNSL Survey

You have the opportunity to make a difference by sharing your experience and insights related to Primary Central Nervous System Lymphoma (PCNSL)!

Read More
January 14, 2025
Early Data for Glioblastoma Vaccine

A clinical trial of the CVGBM cancer vaccine showed positive T-cell responses in over 75% of glioblastoma patients.

Read More
December 12, 2024
PCNSL Patients, Your Voice Matters

Patient and care partner survey, your opportunity to share your experience and insights about Primary Central Nervous System Lymphoma (PCNSL).

Read More
December 9, 2024
IMVAX IGV-001 New Safety Data

Imvax Presents Early Safety Data on Lead Program, IGV-001, at 2024 SNO Annual Meeting.

Read More
December 5, 2024
Patient and Care Partner Survey

Patient and care partner survey, your opportunity to share your experience and insights about Primary Central Nervous System Lymphoma (PCNSL).

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram